Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

NCT01336751 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin glargine
DRUG: 75% insulin lispro protamine suspension and 25 % insulin lispro injection

Sponsor

Sanofi